R

Rocket Pharmaceuticals
D

RCKT

10.470
USD
-0.39
(-3.59%)
مغلق
حجم التداول
34,930
الربح لكل سهم
-3
العائد الربحي
-
P/E
-4
حجم السوق
1,113,349,280
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    A
    ASTC
    0.03000
    (0.46%)
    6.53000 USD
    BA
    BA
    -3.550
    (-1.96%)
    177.320 USD
    GD
    GD
    -3.190
    (-1.30%)
    243.110 USD
    K
    KTOS
    -0.690
    (-2.65%)
    25.300 USD
    LMT
    LMT
    4.07
    (0.93%)
    440.69 USD
    NOC
    NOC
    9.80
    (2.24%)
    447.96 USD
    RTX
    RTX
    -1.830
    (-1.46%)
    123.290 USD
    S
    SPCE
    -0.18000
    (-4.06%)
    4.25000 USD
    U
    U
    0.325
    (1.16%)
    28.335 USD
    المزيد
الأخبار
المقالات

العنوان: Rocket Pharmaceuticals

القطاع: Healthcare
الصناعة: Biotechnology
Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis.